PMID: 8970973Dec 1, 1996Paper

The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor

Journal of Virology
T E ThorneScott M Laster

Abstract

Most cell types are resistant to apoptosis induced by tumor necrosis factor (TNF) unless the cells are treated with a sensitizing agent. Inhibitors of transcription or translation act as sensitizing agents, as do adenoviruses lacking one or more resistance genes. We have reported recently that the activity of cytosolic phospholipase A2 (cPLA2) is necessary for the TNF-induced lysis of cells that are sensitized by inhibitors of transcription or translation (C. Voelkel-Johnson, T. E. Thorne, and S. M. Laster, J. Immunol. 156:201-207, 1996). In this report we have asked whether the lysis of cells infected by the adenovirus dl758 (which lacks the E3 14.7-kDa resistance gene product) also involves the activity of cPLA2. We report that a phosphorothioate-modified antisense oligonucleotide specific for cPLA2, but not the control oligonucleotide, inhibited the TNF-induced release of both [3H]arachidonic acid and 51Cr from infected cells. Arachidonyltrifluoromethyl ketone (AA COCF3), an inhibitor of cPLA2, also inhibited the release of 51Cr, and we found that the release of [3H]arachidonic acid was highly selective and was preferred over the release of [3H]palmitic acid. Taken together, these results suggest strongly that cPLA2 is indee...Continue Reading

References

Mar 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·J M Ostrove, G E Gifford
Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
May 1, 1990·Biochimica Et Biophysica Acta·C G SchalkwijkH Van den Bosch
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H S GinsbergG A Prince
May 1, 1987·European Journal of Immunology·G B DealtryF R Balkwill
Dec 1, 1995·Journal of Virology·H ZhuT Shenk
Jan 1, 1993·Annual Review of Cell Biology·K J Tracey, A Cerami
Jan 29, 1993·Cell·L L LinR J Davis

❮ Previous
Next ❯

Citations

Jul 27, 1999·Lipids·B ChaminadeH Chap
Jun 3, 2000·Annual Review of Immunology·D TortorellaH L Ploegh
Apr 16, 1998·The Journal of Biological Chemistry·P ChenJ T Bruder
May 9, 2003·Cell Biochemistry and Function·Celine PompeiaRui Curi
Sep 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carolyn A Culver, Scott M Laster
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·D WissingM Jäättelä
Dec 24, 2003·International Reviews of Immunology·Drew L LichtensteinWilliam S M Wold
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·David W DraperScott M Laster
May 21, 1998·Antisense & Nucleic Acid Drug Development·L A Marshall, A K Roshak
Aug 20, 2002·The Journal of Biological Chemistry·Lasse FoghsgaardMarja Jaattela
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rita C MaiaScott M Laster
Jun 5, 1998·The American Journal of Physiology·J P FabisiakJ S Lazo
Apr 6, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·K S HarrodJ A Whitsett
Aug 16, 2017·Human Gene Therapy Methods·Adrian HohlPer Sonne Holm
Mar 29, 2001·Progress in Lipid Research·E A Capper, L A Marshall
Mar 19, 2002·Cellular Signalling·David J MacEwan
Jan 18, 2003·Biochimica Et Biophysica Acta·Makoto Mark Taketo, Masahiro Sonoshita
Oct 6, 1997·Journal of Virology·L Foghsgaard, M Jäättelä
Jan 24, 2004·Brain Research. Brain Research Reviews·John W Phillis, Michael H O'Regan
Oct 21, 2006·Biochimica Et Biophysica Acta·Masako Nakanishi, Daniel W Rosenberg
Jul 14, 1999·Cell Biochemistry and Biophysics·L A Wolf, S M Laster
Sep 13, 2011·Nutrition·Undurti N Das

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis